Table 3

Six-month clinical outcomes

	BMS (n=18)	MSG (n=19)	p value
Death (total)	0 (0%)	0 (0%)	1.00
Hierarchical MACE at 6 months	2 (11.1%)	1 (5.3%)	0.52
Clinically driven TLR	1 (5.6%)	1 (5.3%)	0.74
Clinically driven TVR	1 (5.6%)	0 (0%)	0.49
Target lesion-related MI	0 (0%)	1 (5.3%)	0.32
Stent thrombosis	0 (0%)	0 (0%)	1.00

BMS, bare metal stent; MACE, major adverse cardiac event; MI, myocardial infarction; MSG, microengineered stent grooves; TLR, target lesion revascularisation; TVR, target vessel revascularisation.